Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study
- 1 December 2004
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 17 (12) , 1545-1554
- https://doi.org/10.1038/modpathol.3800229
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer DatabasesJournal of Clinical Oncology, 2003
- The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices fornode-negative breast cancerEuropean Journal of Surgical Oncology, 1999
- Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor MarkersJNCI Journal of the National Cancer Institute, 1996
- PRACTICALp-VALUE ADJUSTMENT FOR OPTIMALLY SELECTED CUTPOINTSStatistics in Medicine, 1996
- Immunohistochemical Detection of Hormone Receptors in Breast Carcinomas (ER-ICA, PgR-ICA): Prognostic Usefulness and Comparison with the Biochemical Radioactive-Ligand-Binding Assay (DCC)Gynecologic Oncology, 1994
- Oestrogen receptor, progesterone receptor, pS2, ERD5, HSP27 and cathepsin D in invasive ductal breast carcinomasHistopathology, 1993
- Evaluating the Potential Usefulness of New Prognostic and Predictive Indicators on Node-Negative Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1993
- Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast CancerJNCI Journal of the National Cancer Institute, 1993
- Progesterone receptor determined by immunocytochemical and biochemical methods in human breast cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Breast Cancer Prognostic Factors: Evaluation GuidelinesJNCI Journal of the National Cancer Institute, 1991